Physician profile
David Lim
NPI 1841272564
$2,885.92
in general payments reported to CMS, 2019-2025
32 companies · $686 in 2025
The $686 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $38.17 · 2021: $99.82 · 2022: $414 · 2023: $374 · 2024: $920 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331 · Travel and Lodging: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,331.33 |
| Travel and Lodging | $648.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $648.19 | 2024 | |
| Boston Scientific Corporation | $377.02 | 2019-2024 | Spaceoar Vue System - 10ml |
| Abbvie INC. | $231.48 | 2020-2025 | |
| Abc Home Medical Supply, INC. | $193.30 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $189.04 | 2023-2025 | Bard Urinary Drainage Bag |
| Depuy Synthes Sales INC. | $139.41 | 2023 | Na |
| Astellas Pharma US INC | $118.17 | 2019-2022 | |
| Endo USA, INC. | $115.85 | 2024-2025 | Xiaflex |
| Medtronic, INC. | $89.08 | 2025 | Ligasure |
| Amgen INC. | $86.60 | 2019 | |
| Janssen Biotech, INC. | $68.31 | 2022-2024 | Erleada |
| Bluewind Medical | $62.18 | 2025 | Revi |
| Antares Pharma, INC. | $61.98 | 2024-2025 | Xyosted |
| Ambu INC. | $57.38 | 2024-2025 | |
| 180 Medical, INC. | $49.19 | 2022-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $44.58 | 2025 | Jatenzo, Eligard |
| Sumitomo Pharma America, INC. | $42.97 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $32.10 | 2025 | Provenge |
| Telix Pharmaceuticals | $24.69 | 2023 | Illuccix |
| Progenics Pharmaceuticals, INC. | $24.17 | 2022 | |
| Endo Pharmaceuticals INC. | $23.59 | 2023 | Xiaflex |
| Corcept Therapeutics | $23.07 | 2024 | Korlym |
| Olympus America INC. | $22.53 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.70 | 2025 | |
| Ethicon US, LLC | $20.64 | 2021 | |
| Acella Pharmaceuticals, LLC | $20.59 | 2025 | NP Thyroid 60 |
| Recordati_rare_diseases_inc. | $19.57 | 2025 | Isturisa |
| Azurity Pharmaceuticals, INC. | $18.03 | 2025 | Azmiro |
| Kowa Pharmaceuticals America, INC. | $16.76 | 2022 | |
| Biotissue Holdings INC. | $15.31 | 2022 | |
| Integra Lifesciences Corporation | $15.06 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Allergan, INC. | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.